Sesen Bio (SESN) Announces Significant Commercial Progress as Company Approaches the Potential Approval and Launch of Vicineum in the US

Sesen Bio Announces Significant Commercial Progress as the Company Approaches the Potential Approval and Launch of Vicineum™ in the US

Hiring of the US sales force is 97% complete and sales training has commenced

14 Key Opinion Leader (KOL) speakers have been identified and speaker training has commenced

Two-pronged market access and reimbursement strategy has commenced

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sesen Bio (Nasdaq: SESN), a late-stage... More